Product NewsDrug discovery > Lead Discovery SAFC announces new Proligo reagents at the TIDES conference
Product NewsDrug discovery > Lead Discovery Oxford Biomedica reports encouraging preclinical data with Retinostat® in Retinopathy and demonstrates the potential of Lentivector® in other ocular diseases
Product NewsSeparations An Improved Solid-phase Extraction Product for the Banned Antibiotic Chloramphenicol
Product NewsDrug discovery > Lead Discovery Soluble LAG-3 Protein is a Prognostic Factor in Breast Cancer
Product NewsLife Sciences Unmet Medical Needs, Positive Regulatory Frameworks and Increased Investments Support Continued Stem Cell Research
Product NewsLife Sciences PERKINELMER PROVIDES COMPREHENSIVE SOLUTIONS FOR COLLABORATION ON NIH ROADMAP INITIATIVE
Product NewsClinical Diagnostics EMEA Adopts Positive Opinion on First European Product Containing Delta Biotechnology’s Recombumin® (recombinant human albumin)
Product NewsSpectroscopy Thermo Launches Groundbreaking Blend Analysis NIR Solution to Aid PAT Implementation
Product NewsDrug discovery > Lead Discovery TopoTarget reports promising Phase II trial results with Avugane™ in acne vulgaris
Product NewsDrug discovery > Lead Discovery TopoTarget and CuraGen present encouraging new preclinical data on PXD101 at the AACR 97th Annual Meeting
Product NewsDrug discovery > Lead Discovery BioProgress launches new anti-snoring and caffeine products
Product NewsDrug discovery > Lead Discovery PowderMed’s Therapeutic DNA Vaccine for Chronic Hepatitis B Enters Phase I Clinical Trials in Patients
Product NewsDrug discovery > Lead Discovery TopoTarget and CuraGen announce initiation of first NCI-sponsored clinical trial with PXD101
Product NewsDrug discovery > Lead Discovery New PharmaMedDevice™ Conference and Exhibition Focuses on the Convergence of Medical Device, Pharmaceutical and Biologic Industries
Product NewsLife Sciences Ablynx reveals power of Nanoclone™ - A high throughput method for isolating highly potent antibody-derived therapeutic proteins (Nanobodies™)
Product NewsLife Sciences Oxford Biomedica plc preliminary results for the year ended 31 December 2005
Product NewsDrug discovery > Target Discovery Inpharmatica Extends Admensa Interactive™ Drug Discovery Tools
Product NewsLife Sciences New CD136 (RON)-PE RUO Monoclonal Antibody Identifies Potential Marker of Epithelial Cells
Product NewsDrug discovery > Lead Discovery Première homologation, par la FDA, de Rituxan (MabThera) dans le traitement de la polyarthrite rhumatoïde
Product NewsLife Sciences Ultrafast Sequencing Boosts Target Identification in Diarylquinoline Drug Research
Product NewsLife Sciences Malignant melanoma identified as disease target for YP004, York Pharma’s skin cancer programme
Product NewsDrug discovery > Lead Discovery TopoTarget initiates pivotal Phase II trial with Savicol™ for FAP (an inherited pre-disposition to develop colon cancer)
Product NewsDrug discovery > Lead Discovery Hybrigenics acquires worldwide rights to inecalcitol, a vitamin D analogue
